PBM
EIGR
Propel Bio Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $423K | Hold |
146,381
| – | – | 0.51% | 14 |
|
|
2025
Q1 | $423K | Hold |
146,381
| – | – | 0.49% | 17 |
|
|
2024
Q4 | $765K | Hold |
146,381
| – | – | 0.76% | 16 |
|
|
2024
Q3 | $1.24M | Hold |
146,381
| – | – | 0.72% | 16 |
|
|
2024
Q2 | $1.85M | Hold |
146,381
| – | – | 1.2% | 16 |
|
|
2024
Q1 | $732K | Sell |
146,381
-4,245,051
| -97% | -$21.2M | 0.43% | 24 |
|
|
2023
Q4 | $986K | Buy |
+4,391,432
| New | +$986K | 0.82% | 25 |
|